{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:54:19Z","timestamp":1782572059457,"version":"3.54.5"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,6,15]]},"DOI":"10.2169\/internalmedicine.4551-24","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T22:15:52Z","timestamp":1732745752000},"page":"1843-1848","source":"Crossref","is-referenced-by-count":2,"title":["Olmesartan-associated Gastritis Observed Over Time"],"prefix":"10.2169","volume":"64","author":[{"given":"Mizuho","family":"Fujisawa","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Yoshizaki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Urakami","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Ashizaki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Hoki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Ishida","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Hori","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chise","family":"Ueda","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Abe","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Takao","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"},{"name":"Division of Gastroenterology, International Clinical Cancer Research Center, Kobe University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Morita","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"},{"name":"Division of Gastroenterology, International Clinical Cancer Research Center, Kobe University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Toyonaga","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Kodama","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Haining H, Lanfang L, Mingli W, et al. Antibiotics and antibiotic-associated diarrhea: a real-world disproportionality study of the FDA adverse event reporting system from 2004 to 2022. BMC Pharmacol Toxicol 24: 73, 2023.","DOI":"10.1186\/s40360-023-00710-w"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Lanas A, Garc\u00eda-Rodr\u00edguez LA, Arroyo MT, et al; the Investigators of the Asociaci\u00f3n Espa\u00f1ola de Gastroenterolog\u00eda (AEG). Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 55: 1731-1739, 2006.","DOI":"10.1136\/gut.2005.080754"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Law EH, Badowski M, Hung YT, Weems K, Sanchez A, Lee TA. Association between proton pump inhibitors and microscopic colitis. Ann Pharmacother 51: 253-263, 2017.","DOI":"10.1177\/1060028016673859"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tang SQ, Tang LL, Mao YP, et al. The pattern of time to onset and resolution of immune-related adverse events caused by immune checkpoint inhibitors in cancer: a pooled analysis of 23 clinical trials and 8,436 patients. Cancer Res Treat 53: 339-354, 2021.","DOI":"10.4143\/crt.2020.790"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rubio-Tapia A, Herman ML, Ludvigsson JF, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 87: 732-738, 2012.","DOI":"10.1016\/j.mayocp.2012.06.003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ianiro G, Bibb\u00f2 S, Montalto M, Ricci R, Gasbarrini A, Cammarota G. Systematic review: sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther 40: 16-23, 2014.","DOI":"10.1111\/apt.12780"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Storozuk T, Brown I, Lagana S, et al. The histological spectrum of ARB-induced gastritis. Histopathology 81: 653-660, 2022.","DOI":"10.1111\/his.14766"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shenbagaraj L, Swift G. Olmesartan-associated severe gastritis and enteropathy. BMJ Case Rep 11: e226133, 2018.","DOI":"10.1136\/bcr-2018-226133"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Dong YH, Jin Y, Tsacogianis TN, He M, Hsieh PH, Gagne JJ. Use of olmesartan and enteropathy outcomes: a multi-database study. Aliment Pharmacol Ther 47: 792-800, 2018.","DOI":"10.1111\/apt.14518"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. You SC, Park H, Yoon D, Park S, Joung B, Park  RW. Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study. Korean J Intern Med 34: 90-98, 2019.","DOI":"10.3904\/kjim.2017.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Changqing M, Jason YP, Elizabeth AM, et al. A comparative clinicopathologic study of collagenous gastritis in children and adults: the same disorder with associated immune-mediated diseases. Am J Surg Pathol 39: 802-812, 2015.","DOI":"10.1097\/PAS.0000000000000441"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mart\u00edn-Lagos Maldonado A, Garc\u00eda-Consuegra Ruiz-Arag\u00f3n F, Herrera Mercader MDC. Atrophic enteropathy refractory to a gluten-free diet: what should we consider? Rev Esp Enferm Dig 112: 328-329, 2020.","DOI":"10.17235\/reed.2020.6361\/2019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gupta A, Jain P, Gupta L. Olmesartan induced gastritis and enteropathy. Indian J Gastroenterol 43: 684-685, 2024.","DOI":"10.1007\/s12664-023-01382-4"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Matt P, Schoenhoff F, Habashi J, et al; the GenTAC Consortium. Circulating transforming growth factor-\u03b2 in Marfan syndrome. Circulation 120: 526-532, 2009.","DOI":"10.1161\/CIRCULATIONAHA.108.841981"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Garg M, Angus PW, Burrell LM, Herath C, Gibson PR, Lubel JS. Review article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tract. Aliment Pharmacol Ther 35: 414-428, 2012.","DOI":"10.1111\/j.1365-2036.2011.04971.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Xue A, Fowler MR, Silverman J, Sturkie E, Raff E. A rare case of olmesartan-associated enteropathy successfully managed with steroid taper. Cureus 15: e41604, 2023.","DOI":"10.7759\/cureus.41604"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hartranft ME, Regal RE.  "Triple phase" budesonide capsules for the treatment of olmesartan-induced enteropathy. Ann Pharmacother 48: 1234-1237, 2014.","DOI":"10.1177\/1060028014540608"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/12\/64_4551-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:00:44Z","timestamp":1750478444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/12\/64_4551-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,15]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4551-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,15]]},"article-number":"4551-24"}}